As artificial intelligence tools become increasingly embedded in clinical workflows, a fundamental question has emerged: when an AI system makes a mistake that harms a patient, who should be held accountable? The American Medical Association has now provided an answer that could reshape the legal landscape of healthcare technology.

In a framework released last week, the AMA delineated liability for clinical AI across three distinct stakeholder groups: physicians, AI developers, and healthcare organizations that deploy these tools. The move addresses mounting physician anxiety about being held solely responsible for AI failures they cannot detect or control—a concern that has become a significant barrier to adoption.

Physicians Demand Legal Clarity Before Embracing AI

The urgency behind the AMA's framework becomes clear in recent survey data: one-third of physicians identified clear liability frameworks as the primary driver for AI adoption. Without legal protections, many clinicians remain hesitant to integrate AI into their practice, even when tools promise efficiency gains or improved diagnostic accuracy.

The framework establishes that physicians retain responsibility for their clinical judgment and final treatment decisions, but crucially, they cannot be held liable for AI errors they cannot detect or control. Jennifer Goldsack, Head of the AMA Center on Digital Health and AI, emphasized that physicians should not serve as the sole safety net for AI failures—particularly when dealing with "black box" algorithms that operate without transparency.

The same AMA survey revealed a troubling training gap: 25% of physicians have received no AI training whatsoever, while 92% expressed interest in more education. This disconnect underscores the framework's emphasis on deployer responsibilities for comprehensive training programs.

A Three-Way Split: Developers, Deployers, and Doctors

Under the AMA framework, AI developers bear responsibility for designing safe tools and providing users with detailed information about intended use, performance metrics, and limitations—going well beyond basic legal disclaimers. The framework also suggests that monitoring responsibility for generative AI-enabled medical devices should shift toward developers rather than providers, a change that would particularly benefit small and rural healthcare organizations with limited technical resources.

Healthcare organizations that deploy AI tools must conduct pre-implementation evaluations, establish training programs, monitor ongoing performance for model drift, and maintain adverse event response protocols. These requirements address the reality that AI systems can degrade over time as data patterns shift.

For patients, the framework establishes clearer pathways for recourse and compensation when AI failures cause harm, while aiming to reduce such incidents by clarifying stakeholder responsibilities proactively.

Regulatory Momentum Builds

The AMA's framework arrives as provider groups have submitted comments to the Food and Drug Administration on its proposed approach to regulating generative AI-enabled medical devices. The convergence of professional guidance and regulatory attention signals that the era of ambiguous AI accountability may be drawing to a close.

As clinical AI tools gain increasingly autonomous capabilities, the question of liability has evolved from theoretical concern to practical necessity. The AMA's tripartite framework represents a critical first step toward ensuring that innovation in medical AI doesn't come at the cost of physician vulnerability or patient safety.

Sources

  1. AI vendors, health systems join physicians in liability for clinical AI — Healthcare Dive